Loading company…
Massachusetts medical firm offering whole genome sequencing-based diagnostics for rare genetic disorders, reproductive genetics and oncology.
Established in 2014 by Haim Neerman and Tomer Jackman and based in Framingham, Massachusetts, Variantyx, Inc. provides molecular diagnostics using whole genome sequencing. Its tests cover rare genetic disorders, reproductive genetics, tumor profiling through OncoAlly, wellness testing and genomic profiling for pharmaceutical research. In April 2024 it raised USD 36 million in venture funding from Peregrine Ventures, Pitango Venture Capital, New Era Capital Partners and Robert Bosch Venture Capital. It is at Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in